Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Reynolds

Showing results (181-190 of 212) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641Douglas R Strother, Wendy B London, Mary Lou Schmidt, et al.
Science Translational Medicine|May 18, 2018
Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastomaTimothy L Lochmann, Krista M Powell, Jungoh Ham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Molecular characterization of the pediatric preclinical testing panelGeoffrey Neale, Xiaoping Su, Christopher L Morton, et al.
Pediatric Blood & Cancer|May 7, 2011
Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing programPeter J Houghton, Richard Lock, Hernan Carol, et al.
Cancer Research|August 7, 2016
Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse AnalysisBrendan Murphy, Han Yin, John M Maris, et al.
Pediatric Blood & Cancer|September 17, 2013
Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing ProgramHernan Carol, Richard Gorlick, E Anders Kolb, et al.
EMBO Molecular Medicine|December 17, 2020
Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumorMaggie H Chasse, Benjamin K Johnson, Elissa A Boguslawski, et al.
Pediatric Blood & Cancer|April 20, 2016
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk NeuroblastomaJudith G Villablanca, Samuel L Volchenboum, Hwangeui Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summaryPeter J Houghton, Peter C Adamson, Susan Blaney, et al.
Cancer Research|January 11, 2007
Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysisCraig C Whiteford, Sven Bilke, Braden T Greer, et al.
Pageof 22

Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641Douglas R Strother, Wendy B London, Mary Lou Schmidt, et al.
Science Translational Medicine|May 18, 2018
Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastomaTimothy L Lochmann, Krista M Powell, Jungoh Ham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Molecular characterization of the pediatric preclinical testing panelGeoffrey Neale, Xiaoping Su, Christopher L Morton, et al.
Pediatric Blood & Cancer|May 7, 2011
Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing programPeter J Houghton, Richard Lock, Hernan Carol, et al.
Cancer Research|August 7, 2016
Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse AnalysisBrendan Murphy, Han Yin, John M Maris, et al.
Pediatric Blood & Cancer|September 17, 2013
Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing ProgramHernan Carol, Richard Gorlick, E Anders Kolb, et al.
EMBO Molecular Medicine|December 17, 2020
Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumorMaggie H Chasse, Benjamin K Johnson, Elissa A Boguslawski, et al.
Pediatric Blood & Cancer|April 20, 2016
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk NeuroblastomaJudith G Villablanca, Samuel L Volchenboum, Hwangeui Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summaryPeter J Houghton, Peter C Adamson, Susan Blaney, et al.
Cancer Research|January 11, 2007
Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysisCraig C Whiteford, Sven Bilke, Braden T Greer, et al.
Pageof 22